IDEAYA Biosciences, Inc., a precision medicine oncology company, has announced the issuance of non-qualified stock options to nine newly hired employees, under its 2023 Employment Inducement Incentive Award Plan. The stock options, totaling 664,600 shares, are granted as an inducement for employment under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $20.05 per share, matching the closing price of IDEAYA's common stock on the grant date, and come with a 10-year term. Vesting occurs over four years, with 25% vesting on the first anniversary and the remainder vesting monthly over the next three years, contingent upon continued employment.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。